Islet encapsulation: Strategies to enhance islet cell functions

Tissue Engineering

Volumn 13, Issue 3, 2007, Pages 589-599

  Beck, Jonathan ^a,b   Angus, Ryan ^a   Madsen, Ben ^a   Britt, David ^a   Vernon, Brent ^c   Nguyen, Kytai T ^a,d,e  

^a Utah State University   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Arizona State University   (United States)

^d UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^e The University of Texas at Arlington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; ENCAPSULATION; INSULIN; PATIENT TREATMENT; TISSUE ENGINEERING;

CELL SOURCES; CELL VIABILITY; ENCAPSULATION METHODS;

MEDICAL PROBLEMS;

ALGINIC ACID; COPOLYMER; MACROGOL; POLYLYSINE; POLYSULFONE; POLYVINYL ALCOHOL;

ALTERNATIVE MEDICINE; BIOCOMPATIBILITY; CELL FUNCTION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CELL VIABILITY; DIABETES MELLITUS; EFFECTOR CELL; EMBRYONIC STEM CELL; ENCAPSULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN TREATMENT; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW; TECHNIQUE; XENOGRAFT;

ANIMALS; CAPSULES; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; TISSUE ENGINEERING; UNITED STATES;

EID: 34147193338     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0183     Document Type: Review

References (117)

1. Olefsky, J.M. Prospects for research in diabetes mellitus. JAMA 2001;285(5):628-632.
2. Walsh, G. Biopharmaceuticals: recent approvals and likely directions. Trends Biotechnol 23, 553, 2005.
3. Deedwania, P.C., Fonseca, V.A. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 118, 939, 2005.
4. Sheetz, M.J., King, G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288, 2579, 2002.
5. Jun, H.S., Yoon, J.W. Approaches for the cure of type 1 diabetes by cellular and gene therapy. Curr Gene Ther 5, 249, 2005.
6. Furlan, R., Butti, E., Piuchino S., et al. Gene therapy for autoimmune diseases. Curr Opin Mol Ther 6, 525, 2004.
7. Chuah, M.K. Cutting through the obstacles and resurrecting the promise of gene therapy. IDrugs 8, 818, 2005.
8. Giannoukakis, N., Trucco, M. Gene therapy for type 1 diabetes: a proposal to move to the next level. Curr Opin Mol Ther 7, 467, 2005.
9. Yechoor, V., Chan, L. Gene therapy progress and prospects: gene therapy for diabetes mellitus. Gene Ther 12, 101, 2005.
10. Catargi, B. Current status and future of implantable insulin pumps for the treatment of diabetes. Expert Rev Med Devices 1, 181, 2004.
11. Renard, E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2, 708, 2002.
12. Chia, C.W., Saudek, C.D. Glucose sensors: toward closed loop insulin delivery. Endocrinol Metab Clin North Am 33, 175, 2004.
13. Steil, G.M., Panteleon, A.E., Rebrin, K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev 56, 125, 2004.
14. Steil, G.M., Rebrin, K. Closed-loop insulin delivery-what lies between where we are and where we are going? Expert Opin Drug Deliv 2, 353, 2005.
15. Soon-Shiong, P. Treatment of type I diabetes using encapsulated islets. Adv Drug Deliv Rev 35, 259, 1999.
16. Kizilel, S., Garfinkel, M., Opara, E. The bioartificial pancreas: progress and challenges. Diabetes Technol Ther 7,968, 2005.
17. Antonios, G. Mikos MGPSKSLIRCT. Mini-review: islet transplantation to create a bioartificial pancreas. Biotechnol Bioeng 43, 673, 1994.
18. Efrat, S. Cell replacement therapy for type 1 diabetes. Trends Mol Med. 8, 334, 2002.
19. Kendall, W.F., Jr., Darrabie, M.D., El-Shewy, H.M., et al. Effect of alginate composition and purity on alginate microspheres. J Microencapsul 21, 821, 2004.
20. de Groot, M., Schuurs, T.A., Leuvenink, H.G., et al. Macrophage overgrowth affects neighboring nonovergrown encapsulated islets. J Surg Res 115, 235, 2003.
21. Ma, X., Vacek, I., Sun, A. Generation of alginate-poly-1-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions. Artif Cells Blood Substit Immobil Biotechnol 22, 43, 1994.
22. Korbutt, G.S., Mallett, A.G., Ao, Z., et al. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 47, 1810, 2004.
23. Orive G., Hernaandez, R.M., Rodrâiguez Gascâon, A., et al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol 22, 87, 2004.
24. Orive, G., Tam, S.K., Pedraz, J.L., et al. Biocompatibility of alginate-poly-1-lysine microcapsules for cell therapy. Biomaterials 27, 3691, 2006.
25. Cui, W., Barr, G., Faucher, K.M., et al. A membrane-mimetic barrier for islet encapsulation. Transplant Proc May 36, 1206, 2004.
26. Dusseault, J., Leblond, F.A., Robitaille, R., et al. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials May 26, 1515, 2005.
27. Petersen, P., Lembert, N., Zschocke, P., et al. Hydroxymethylated polysulphone for islet macroencapsulation allows rapid diffusion of insulin but retains PERV. Transplant Proc 34, 194, 2002.
28. Figliuzzi, M., Cornolti, R., Plati, T., et al. Subcutaneous xenotransplantation of bovine pancreatic islets. Biomaterials 26, 5640, 2005.
29. Xie, D., Smyth, C.A., Eckstein, C., et al. Cytoprotection of PEG-modified adult porcine pancreatic islets for improved xenotransplantation. Biomaterials 26, 403, 2005.
30. Cruise, G.M., Hegre, O.D., Scharp, D.S., et al. A sensitivity study of the key parameters in the interfacial photopolymerization of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol Bioeng 57, 655, 1998.
31. Boninsegna, S., Bosetti, P., Carturan, G., et al. Encapsulation of individual pancreatic islets by sol-gel SiO2: a novel procedure for perspective cellular grafts. J Biotechnol 100, 277, 2003.
32. Desai, T.A., West, T., Cohen, M., et al. Nanoporous microsystems for islet cell replacement. Adv Drug Deliv Rev 56, 1661, 2004.
33. Mahgoub, M.A., Ammar, A., Fayez, M., et al. Neovascularization of the amniotic membrane as a biological immune barrier. Transplant Proc 36, 1194, 2004.
34. Vernon, B., Kim, S.W., Bae, Y.H. Thermoreversible copolymer gels for extracellular matrix. J Biomed Mater Res 51, 69, 2000.
35. Shapiro, A.M., Lakey, J.R., Ryan, E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343, 230, 2000.
36. Orive, G., Gascâon, A.R., Hernâandez, R.M., et al. The search for new beta-cell sources. Trends Biotechnol 22, 612, 2004.
37. Matsumoto, S., Okitsu, T., Iwanaga, Y., et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365, 1642, 2005.
38. Nir, T., Dor, Y. How to make pancreatic beta cells-prospects for cell therapy in diabetes. Curr Opin Biotechnol 16, 524, 2005.
39. Zhang, Y.Q., Kritzik, M., Sarvetnick, N. Identification and expansion of pancreatic stem/progenitor cells. J Cell Mol Med 9, 331, 2005.
40. Zhang, Y.Q., Sarvetnick, N. Development of cell markers for the identification and expansion of islet progenitor cells. Diabetes Metab Res Rev 19, 363, 2003.
41. Bodnar, C.A., Sen, A., Kallos, M.S., et al. Characterization of human islet-like structures generated from pancreatic precursor cells in culture. Biotechnol Bioeng 93, 980, 2006.
42. Hao, E., Tyrberg, B., Itkin-Ansari, P., et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 12, 310, 2006.
43. Otonkoski, T., Gao, R., Lundin, K. Stem cells in the treatment of diabetes. Ann Med 37, 513, 2005.
44. Brolâen, G.K., Heins, N., Edsbagge, J., et al. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing beta-cell-like cells. Diabetes 54, 2867, 2005.
45. Lumelsky, N., Blondel, O., Laeng, P., et al. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389, 2001.
46. Di Gioacchino, G., Di Campli, C., Zocco, M.A., et al. Transdifferentiation of stem cells in pancreatic cells: state of the art. Transplant Proc 37, 2662, 2005.
47. Murtaugh, L.C., Law, A.C., Dor, Y., et al. Beta-catenin is essential for pancreatic acinar but not islet development. Development 132, 4663, 2005.
48. Lammert, E., Gu, G., McLaughlin, M., et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13, 1070, 2003.
49. Lammert, E., Cleaver, O., Melton, D. Induction of pancreatic differentiation by signals from blood vessels. Science 294, 564, 2001.
50. Vaca, P., Martâin, F., Vegara-Meseguer, J.M., et al. Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. Stem Cells 24, 258, 2006.
51. Soria, B., Roche, E., Reig, J.A., et al. Generation of insulin-producing cells from stem cells. Novartis Found Symp 265, 158, 2005.
52. Leâon-Quinto, T., Jones, J., Skoudy, A., et al. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 47, 1442, 2004.
53. Hori, Y., Gu, X., Xie, X., et al. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2, e103, 2005.
54. Burns, C.J., Minger, S.L., Hall, S., et al. The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem Biophys Res Commun 326, 570, 2005.
55. Kodama, S., Kèuhtreiber, W., Fujimura, S., et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 14 302, 1223, 2003.
56. Itkin-Ansari, P., Levine, F. Sources of beta-cells for human cell-based therapies for diabetes. Cell Biochem Biophys 40, 103, 2004.
57. Fleischer, N., Chen, C., Surana, M., et al. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 47, 1419, 1998.
58. Milo-Landesman, D., Surana, M., Berkovich, I., et al. Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the let-on regulatory system. Cell Transplant 10, 645, 2001.
59. Simpson, N.B., Khokhlova, N., Oca-Cossio, J.A., et al. Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitro. Biomaterials 26, 4633, 2005.
60. Ramiya, V., Schatz, D. Islet replacement vs. regeneration: hope or hype? Pediatr Diabetes. 5, 45, 2004.
61. Specke, V., Schuurman, H.J., Plesker, R., et al. Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol 9, 281, 2002.
62. Chaudhari, M., Cornelius, J.G., Schatz, D., et al. Pancreatic stem cells: a therapeutic agent that may offer the best approach for curing type 1 diabetes. Pediatr Diabetes 2, 195, 2001.
63. Burns, C.J., Persaud, S.J., Jones, P.M. Stem cell therapy for diabetes: do we need to make beta cells? J Endocrinol 183, 437, 2004.
64. Contreras, J.L., Xie, D., Mays, J., et al. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 136, 537, 2004.
65. Sattar, S.P., Shakeel, Ahmed, M., Majeed, F., et al. Inert medication ingredients causing nonadherence due to religious beliefs. Ann Pharmacother 38, 621, 2004.
66. Monaco, A.P., Maki, T., Ozato, H., et al. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg 214, 339, 1991; discussion 361.
67. Sullivan, S.J., Maki, T., Borland, K.M., et al. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 252, 718, 1991.
68. Qi, M., Gu, Y., Sakatu, N., et al. PVA hydrogel sheet macroencapsulation for the bioartificial pancreas. Biomaterials 25, 5885, 2004.
69. Chang, T.M. Semipermeable microcapsules. Science 146, 524, 1964.
70. Cruise, G.M., Hegre, O.D., Lamberti, F.V., et al. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8, 293, 1999.
71. Loscertales, I.G., Barrero, A., Guerrero, I., et al. Micro/nano encapsulation via electrified coaxial liquid jets. Science 295, 1695, 2002.
72. van Schilfgaarde, R., de Vos, P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med 77, 199, 1999.
73. Marchetti, P., Del Prato, S., Lupi, R., et al. The pancreatic beta-cell in human type 2 diabetes. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis 16, S3, 2006.
74. Nanji, S.A., Shapiro, A.M. Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab 8, 15, 2006.
75. Cleveland, J.C., Jr., Raeburn, C., Harken, A.H. Clinical applications of ischemic preconditioning: from head to toe. Surgery 129, 664, 2001.
76. Toosy, N., McMorris, E.L., Grace, P.A., et al. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 84, 489, 1999.
77. Bellmann, K., Wenz, A., Radons, J., et al. Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J Clin Invest, 95, 2840, 1995.
78. Wright, J.R., Jr., Yang, H., Dooley, K.C. Tilapia-a source of hypoxia-resistant islet cells for encapsulation. Cell Transplant 7, 299, 1998.
79. Wang, W., Gu, Y., Tabula, Y., et al. Reversal of diabetes in mice by xenotransplantation of a bioartificial pancreas in a prevascularized subcutaneous site. Transplantation 73, 122, 2002.
80. Trivedi, N., Steil, G.M., Colton, C.K., et al. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant 9, 115, 2000.
81. de Groot, M., Schuurs, T.A., van Schilfgaarde, R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 121, 141, 2004.
82. Siebers, U., Horcher, A., Bretzel, R.G., et al. Transplantation of free and microencapsulated islets in rats: evidence for the requirement of an increased islet mass for transplantation into the peritoneal site. Int J Artif Organs 16, 96, 1993.
83. Dufrane, D., Steenberghe, M., Goebbels, R.M., et al. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27, 3201, 2006.
84. Schneider, S., von Mach, M.A., Kraus, O., et al. Intraportal transplantation of allogenic pancreatic islets encapsulated in barium alginate beads in diabetic rats. Artif Organs 27, 1053, 2003.
85. Toso, C., Morel, P., Bucher, P., et al. Insulin independence alter conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. Transplantation 15 76, 1133, 2003.
86. Toso, C., Oberholzer, J., Ceausoglu, I., et al. Intra-portal injection of 400-microm microcapsules in a large-animal model. Transpl Int 16, 405, 2003.
87. De Vos, P., De Haan, B.J., Wolters, G.H., et al. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40, 262, 1997.
88. King, A., Lau, J., Nordin, A., et al. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. Diabetes Technol Ther 5, 653, 2003.
89. King, A., Sandler, S., Andersson, A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 57, 374, 2001.
90. Fritschy, W.M., de Vos, P., Groen, H., et al. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transpl Int 7, 264, 1994.
91. De Vos, P., De Haan, B., Vun Schilfgaarde, R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18, 273, 1997.
92. Lee, D.Y., Nam, J.H., Byun, Y. Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks. J Biomater Sci Polym Ed 15, 753, 2004.
93. Siebers, U., Horcher, A., Brandhorst, H., et al. Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation. J Mol Med 77, 215, 1999.
94. Gray, D.W. An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann N Y Acad Sci 944, 226, 2001.
95. Omer, A., Keegan, M., Czismadia, E., et al. Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 10, 240, 2003.
96. Contreras, J.L., Bilbao, G., Smyth, C.A., et al. Cytoprotection of pancreatic islets before and early after transplantation using gene therapy. Kidney Int 61(1 Suppl), 79, 2002.
97. Rabinovitch, A., Suarez-Pinzon, W., Strynadka, K., et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48, 1223, 1999.
98. Saldeen, J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology 141, 2003, 2000.
99. Wiegand, F., Kroncke, K.D., Kolb-Bachofen, V. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes. Transplantation 56, 1206, 1993.
100. Yang, H., Wright, J.R., Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation 27 67, 815, 1999.
101. Chae, S.Y., Kim, S.W., Bae, Y.H. Effect of cross-linked hemoglobin on functionality and viability of microencapsulated pancreatic islets. Tissue Eng 8, 379, 2002.
102. Chae, S.Y., Lee, M., Kim, S.W., et al. Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin. Biomaterials 25, 843, 2004.
103. Sigrist, S., Mechine-Neuville, A., Mandes, K., et al. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant 12, 627, 2003.
104. Sigrist, S., Mechine-Neuville, A., Mandes, K., et al. Induction of angiogenesis in omentum with vascular endothelial growth factor: influence on the viability of encapsulated rat pancreatic islets during transplantation. J Vase Res 40, 359, 2003.
105. Lai, Y., Schneider, D., Kidszun, A., et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 79, 1530, 2005.
106. Stagner, J., Mokshagundam, S., Wyler, K., et al. Beta-cell sparing in transplanted islets by vascular endothelial growth factor. Transplant Proc 36, 1178, 2004.
107. Hulinsky, I., Harrington, J., Cooney, S., et al. Insulin secretion and DNA synthesis of cultured islets of Langerhans are influenced by the matrix. Pancreas 11, 309, 1995.
108. Hulinsky, I., Cooney, S., Harrington, J., et al. In vitro growth of neonatal rat islet cells is stimulated by adhesion to matrix. Horm Metab Res 27, 209, 1995.
109. Lee, D.Y., Park, S.J., Nam, J.H., et al. A new strategy toward improving immunoprotection in cell therapy for diabetes mellitus: long-functioning PEGylated islets in vivo. Tissue Eng 12, 615, 2006.
110. Ikeda, H., Kobayashi, N., Tanaka, Y., et al. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng 12, 1799, 2006.
111. Cirulli, V., Beattie, G.M., Klier, G., et al. Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrins in the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J Cell Biol 150, 1445, 2000.
112. Kantengwa, S., Baetens, D., Sadoul, K., et al. Identification and characterization of alpha 3 beta 1 integrin on primary and transformed rat islet cells. Exp Cell Res 237, 394, 1997.
113. Ris, F., Hammar, E., Bosco, D., et al. Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro. Diabetologia 45, 841, 2002.
114. Hammar, E.B., Irminger, J.C., Rickenbach, K., et al. Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem 280, 30630, 2005.
115. Pinkse, G.G., Bouwman, W.P., Jiawan-Lalai, R., et al. Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. Diabetes 55, 312, 2006.
116. Nagata, N., Gu, Y., Hori, H., et al. Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant 10, 447, 2001.
117. Close, N., Anand, R., Hering, B., et al. NIH-supported national islet transplantation registry. Cell Biochem Biophys 40(3 Suppl), 9, 2004.